Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.6 | Q1 | 89.5% | 1.565 | Q1 | 92.6% |
| 2024 | 8.2 | Q1 | 89.2% | 1.666 | Q1 | 93.5% |
| 2023 | 6.9 | Q1 | 72.9% | 1.571 | Q1 | 93.2% |
| 2022 | 8.6 | Q1 | 74.1% | 1.588 | Q1 | 93.6% |
| 2021 | 9.4 | Q2 | 74.7% | 1.621 | Q1 | 94.0% |
| 2020 | — | — | 2.175 | Q1 | 96.2% | |
| 2019 | — | — | 2.160 | Q1 | 96.2% | |
| 2018 | — | — | 2.088 | Q1 | 95.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1939-0041
ISSN
1939-5116
country
UScoverage
2009-2026